RUXOLITINIB CIPLA
As listed in the register: RUXOLITINIB CIPLA 15 MG COMPRIMIDOS EFG
15 mg · comprimido
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Ruxolitinib
- Made by
- Cipla Europe N.V.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
Bulgaria2 matching products
European UnionNo exact match for this strength and form
Netherlands8 matching products
- Jakavi 15 mg 15 mg · tablet
- Ruxolitinib Accord 15 mg 15 mg · tablet
- Ruxolitinib Advanz Pharma 15 mg tabletten 15 mg · tablet
- Ruxolitinib Devatis 15 mg 15 mg · tablet
- Ruxolitinib Medichem 15 mg tabletten 15 mg · tablet
- Ruxolitinib MSN 15 mg tabletten 15 mg · tablet
- Ruxolitinib Sandoz 15 mg 15 mg · tablet
- Ruxolitinib Vivanta 15 mg tabletten 15 mg · tablet
SwitzerlandNo exact match for this strength and form
Details
| Made by | Cipla Europe N.V. |
|---|---|
| Active substance | Ruxolitinib |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 15 mg |
| Form | comprimido |
| Classification | L01EJ01 · Cancer treatments and immune-system medicines |
| Route | vía oral |
| Marketed | No — authorised but not currently marketed, according to the register |
| Generic | Yes — a generic medicine, according to the register |
| Driving | The regulator flags that this medicine can affect the ability to drive. |
| Name in the register | RUXOLITINIB CIPLA 15 MG COMPRIMIDOS EFG |
| Nº Registro | 91524 |
Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30 · not reviewed by a clinician
Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA. Reuse terms: Aviso legal AEMPS.
Other strengths and forms
4 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.